Thus, suppression of PAH-induced CYP1A1 activity in the CD-exposed lung is associated with both inflammation and the expansion of an alveolar type II cell population with reduced capacity for BNF-induced AhR nuclear translocation. The gene discussed is CYP1A1; the disease is pulmonary arterial hypertension.